Catheter-associated urinary tract infections in persons with neurogenic bladders.

Todd A Linsenmeyer
Author Information
  1. Todd A Linsenmeyer: a Kessler Institute for Rehabilitation, West Orange, New Jersey; Department of Surgery (Division of Urology), Rutgers - New Jersey Medical School, Newark, New Jersey; Department of Physical Medicine & Rehabilitation, Rutgers - New Jersey Medical School , Newark , New Jersey.

Abstract

This review is based on the author's Donald Munro Lecture given at the annual conference of the Academy of Spinal Cord Injury Professionals in New Orleans, LA. Indwelling catheters play an important role in bladder management following SCI for many individuals with neurogenic bladders. There is an increased risk of UTI compared to other types of bladder management with indwelling urethral catheters but not SP catheters. To minimize the risk of symptomatic UTI, the following steps are essential: prevent bladder wall distention and resulting ischemia, maintain colonization with "good" bacteria, and prevent bladder stones. For individuals with recurrent symptomatic UTIs, try to change the environment, prevent bladder over distention, and make sure the bladder is "quiet" by using strategies such as adequate dosages of anticholinergics, onabotulinum toxin A, and preventing catheter blockage. Bacterial colonization of the bladder is common. However, bacterial colonization may have a positive effect by inhibition of colonization of pathogenic bacteria. Judicious use of antibiotics is important since antibiotics hasten the evolution of more resistant organisms. Potential prevention and treatment strategies include killing the offending organisms, changing the environment (such as urinary acidification), and modifying virulence factors and the bacterial microbiome.

Keywords

References

  1. Cochrane Database Syst Rev. 2008 Oct 08;(4):CD006216 [PMID: 18843708]
  2. Nature. 2012 Jun 13;486(7402):207-14 [PMID: 22699609]
  3. J Spinal Cord Med. 2004;27(1):29-34 [PMID: 15156934]
  4. Spinal Cord. 2013 Sep;51(9):700-4 [PMID: 23896666]
  5. J Urol. 1972 Mar;107(3):458-61 [PMID: 5010715]
  6. Eur Urol. 1994;26(2):137-40 [PMID: 7957468]
  7. JAMA. 1994 Mar 9;271(10):751-4 [PMID: 8093138]
  8. NeuroRehabilitation. 1994;4(4):205-13 [PMID: 24525406]
  9. Arch Intern Med. 1984 Aug;144(8):1585-8 [PMID: 6331806]
  10. J Urol. 2000 Mar;163(3):768-72 [PMID: 10687973]
  11. Genome Res. 2009 Dec;19(12):2317-23 [PMID: 19819907]
  12. Neurourol Urodyn. 2008;27(6):475-9 [PMID: 18551568]
  13. Eur Urol. 2006 Nov;50(5):1058-64 [PMID: 16517054]
  14. Arch Phys Med Rehabil. 2002 Jan;83(1):129-38 [PMID: 11782843]
  15. J Spinal Cord Med. 2003 Winter;26(4):352-7 [PMID: 14992336]
  16. J Spinal Cord Med. 2006;29(5):527-73 [PMID: 17274492]
  17. Br J Dermatol. 2008 Mar;158(3):442-55 [PMID: 18275522]
  18. J Urol. 2010 Jul;184(1):213-7 [PMID: 20478597]
  19. Sci Transl Med. 2013 Jun 19;5(190):190ra80 [PMID: 23785036]
  20. Mayo Clin Proc. 1984 Aug;59(8):523-9 [PMID: 6379319]
  21. Urology. 2011 Aug;78(2):341-6 [PMID: 21683991]
  22. J Spinal Cord Med. 2009;32(4):355-6 [PMID: 19777856]
  23. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61 [PMID: 20847294]
  24. Acta Obstet Gynaecol Jpn. 1972 Jul;19(3):147-53 [PMID: 4587187]
  25. Emerg Med J. 2006 Aug;23(8):649 [PMID: 16858107]
  26. World J Urol. 2014 Feb;32(1):79-84 [PMID: 23633128]
  27. J Spinal Cord Med. 2004;27(1):35-40 [PMID: 15156935]
  28. Spinal Cord. 2000 Dec;38(12):762-5 [PMID: 11175377]
  29. J Clin Microbiol. 2014 Mar;52(3):871-6 [PMID: 24371246]
  30. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004201 [PMID: 15674931]
  31. J Urol. 1977 Apr;117(4):486-8 [PMID: 850323]
  32. J Urol. 2000 Oct;164(4):1285-9 [PMID: 10992382]
  33. J Spinal Cord Med. 2009;32(5):568-73 [PMID: 20025153]
  34. Eur Urol. 2000 Oct;38(4):434-8 [PMID: 11025382]
  35. Cold Spring Harb Perspect Med. 2013 Apr 01;3(4):a010306 [PMID: 23545571]
  36. Diagn Microbiol Infect Dis. 1988 Apr;9(4):197-206 [PMID: 3180705]
  37. Am J Med. 2002 Jul 8;113 Suppl 1A:67S-79S [PMID: 12113873]
  38. Eur Urol. 2009 Mar;55(3):705-11 [PMID: 18814955]
  39. Spinal Cord. 2007 Aug;45(8):542-50 [PMID: 17043681]
  40. Eur Urol. 2008 Mar;53(3):613-8 [PMID: 17804150]

MeSH Term

Anti-Bacterial Agents
Botulinum Toxins, Type A
Catheters, Indwelling
Humans
Spinal Cord Injuries
Urinary Bladder, Neurogenic
Urinary Catheterization
Urinary Tract Infections

Chemicals

Anti-Bacterial Agents
Botulinum Toxins, Type A
onabotulinum toxin A

Word Cloud

Created with Highcharts 10.0.0bladdercatheterscolonizationUTIpreventimportantmanagementfollowingSCIindividualsneurogenicbladdersrisksymptomaticdistentionbacteriaenvironmentstrategiesbacterialantibioticsorganismsurinaryreviewbasedauthor'sDonaldMunroLecturegivenannualconferenceAcademySpinalCordInjuryProfessionalsNewOrleansLAIndwellingplayrolemanyincreasedcomparedtypesindwellingurethralSPminimizestepsessential:wallresultingischemiamaintain"good"stonesrecurrentUTIstrychangemakesure"quiet"usingadequatedosagesanticholinergicsonabotulinumtoxinpreventingcatheterblockageBacterialcommonHowevermaypositiveeffectinhibitionpathogenicJudicioususesincehastenevolutionresistantPotentialpreventiontreatmentincludekillingoffendingchangingacidificationmodifyingvirulencefactorsmicrobiomeCatheter-associatedtractinfectionspersonsCatheterassociatedCAUTIMicrobiomeNeurogenicUrinary

Similar Articles

Cited By